Academic Editor

Tanya Parish


Summary

Tanya Parish is the Senior VP of Drug Discovery at IDRI where she heads the TB Discovery Research group. Her work focuses on the discovery of new drugs that are effective at curing drug-sensitive and drug-resistant tuberculosis with the added goal of shortening the time it takes to cure disease. This encompasses a range of early stage drug discovery including drug target identification and validation, high throughput screening and medicinal chemistry. In addition, her group works to understand the pathogenic mechanisms and basic biology of the global pathogen Mycobacterium tuberculosis and using this information to inform drug discovery.

Tanya is a microbiologist by training, with a background in mycobacteriology. She received her PhD at the National Institute for Medical Research investigating gene regulation in mycobacteria followed by postdoctoral research at the London School of Hygiene & Tropical Medicine studying several facets of the biology of M. tuberculosis. Until recently, she held an academic post as Professor of Mycobacteriology at Barts and the London School of Medicine and Dentistry, and she is currently an Affiliate Professor in the Department of Global Health at the Univ. of Washington.

Tanya has edited several books on mycobacteria and published numerous papers on the basic biology and genetics of M. tuberculosis. She is Editor-in-Chief of Microbiology (UK), on the Editorial Board for PLOS One, PeerJ and Frontiers in Cell and Infection Microbiology.

Biochemistry Global Health Infectious Diseases Microbiology Molecular Biology

Work details

VP of Drug Discovery

Infectious Disease Research Institute
TB Discovery Research

October 7, 2014
3 citations
540 downloads
919 views
, , , , , , ,
https://doi.org/10.7717/peerj.612 PubMed 25320680
September 17, 2014 - Version: 1
75 downloads
361 views
, , , , , , ,
https://doi.org/10.7287/peerj.preprints.502v1

Academic Editor on